GRI Bio (GRI) Cash & Current Investments (2020 - 2026)
GRI Bio (GRI) recorded Cash & Current Investments of $10.95 million in Q2 2026, up 113.7% from $5.12 million a year earlier but down 0.9% from the prior quarter.
GRI Bio (GRI) Cash & Current Investments (2020 - 2026) Analysis & Trends
At the end of FY2025, GRI Bio reported Cash & Current Investments of $8.23 million, up 63.7% from FY2024.
- Annual Cash & Current Investments has a five-year compound annual growth rate of 137.5% (FY2020 to FY2025).
- Across earlier years, Cash & Current Investments came in at $5.03 million in FY2024 (+178.1%), $1.81 million in FY2023, $9,000 in FY2022 (-99.9%) and $7.51 million in FY2021.
- Quarterly Cash & Current Investments has ranged from $9,000 in Q4 2022 to $11.05 million in Q1 2026 over the past five years.
- On a year-over-year basis, Cash & Current Investments has increased for three consecutive quarters, with growth averaging 71.8% over the last eight quarters.
- Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 236.7% in Q1 2026, against a decline of 99.9% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $11.05 million (Q1 2026), $8.23 million (Q4 2025) and $4.06 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | GRI Bio | 2.63 Mn | -31.65 Mn | - | 10.95 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.95 Mn |
| Mar 31, 2026 | 11.05 Mn |
| Dec 31, 2025 | 8.23 Mn |
| Sep 30, 2025 | 4.06 Mn |
| Jun 30, 2025 | 5.12 Mn |
| Mar 31, 2025 | 3.28 Mn |
| Dec 31, 2024 | 5.03 Mn |
| Sep 30, 2024 | 4.75 Mn |
| Jun 30, 2024 | 6.35 Mn |
| Mar 31, 2024 | 4.09 Mn |
| Dec 31, 2023 | 1.81 Mn |
| Sep 30, 2023 | 3.49 Mn |
| Jun 30, 2023 | 4.80 Mn |
| Mar 31, 2023 | 1.67 Mn |
| Dec 31, 2022 | 9,000.00 |
| Sep 30, 2022 | 5.15 Mn |
| Jun 30, 2022 | 6.97 Mn |
| Mar 31, 2022 | 5.18 Mn |
| Dec 31, 2021 | 7.51 Mn |
| Sep 30, 2021 | 9.14 Mn |
GRI Bio Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=GRI&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "GRI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=GRI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();